# Melatonin and the Metabolic Syndrome

> **NCT01038921** · PHASE2 · COMPLETED · sponsor: **Emory University** · enrollment: 39 (actual)

## Conditions studied

- Metabolic Syndrome

## Interventions

- **DRUG:** Melatonin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01038921
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2012-06
- **Final completion:** 2013-07
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2015-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01038921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01038921, "Melatonin and the Metabolic Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01038921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*